Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT1D agonist sumatriptanL Stern, J Zohar, R Cohen, et al.
Brain Research|January 16, 1984
The effects of chronic lithium and ECT on A1 and A2 adenosine receptor systems in rat brainM Newman, J Zohar, M Kalian, et al.
Polish Journal of Pharmacology and Pharmacy|March 1, 1984
Cyclic AMP and GMP in the cerebrospinal fluid after high-dose haloperidol treatmentR H Belmaker, J Zohar, R Rimon, et al.
Neuroscience and Biobehavioral Reviews|December 14, 1999
Is there sexual dimorphism in obsessive-compulsive disorder?J Zohar, R Gross-Isseroff, H Hermesh, et al.
Clinical Neuropharmacology|April 1, 1996
The pathogenesis and treatment of obsessive-compulsive disorderO T Dolberg, I Iancu, Y Sasson, et al.
Harefuah|January 1, 1997
[The serotonin syndrome]L Broude, I Iancu, O T Dolberg, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 12, 1999
Identification of a cis-acting dendritic targeting element in MAP2 mRNAsA Blichenberg, B Schwanke, M Rehbein, et al.
The European Journal of Neuroscience|June 14, 2001
Identification of a cis-acting dendritic targeting element in the mRNA encoding the alpha subunit of Ca2+/calmodulin-dependent protein kinase IIA Blichenberg, M Rehbein, R Müller, et al.
AIMS Microbiology|August 7, 2019
Asgard archaea: Diversity, function, and evolutionary implications in a range of microbiomesFraser MacLeod, Gareth S Kindler, Hon Lun Wong, et al.
Biological Psychiatry|March 1, 1982
Lithium does not prevent agonist-induced subsensitivity of human adenylate cyclaseJ Zohar, B Lerer, R P Ebstein, et al.
Pageof 14